Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemiaGrzegorz Helbig, Sławomira Kyrcz‐Krzemień, Andrzej Moskwa et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 24